Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 68788-8637

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68788-8637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)

Chemical structure of Cyclobenzaprine hydrochloride, depicting the molecular formula with aromatic rings and the HCl component, representing the hydrochloride salt form.*

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 02)

FDA Label Image

Cyclobenzaprine HCl Tablets Usp 10mg (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 03)

Cyclobenzaprine HCl Tablets USP 10 mg film-coated oral tablets label. Contains a warning about drowsiness and alcohol, with directions for use in English and Spanish. The label lists Unichem Laboratories Ltd. as manufacturer and Preferred Pharmaceuticals Inc. as the labeler. Additional product details like lot number, expiration date, and package size fields are visible but not filled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.